 Anti-Retroviral Agents
"Anti-Retroviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used to treat RETROVIRIDAE INFECTIONS.
| Descriptor ID |
D044966
|
| MeSH Number(s) |
D27.505.954.122.388.077
|
| Concept/Terms |
Anti-Retroviral Agents- Anti-Retroviral Agents
- Agents, Anti-Retroviral
- Anti Retroviral Agents
- Antiretroviral Agents
- Agents, Antiretroviral
|
Below are MeSH descriptors whose meaning is more general than "Anti-Retroviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Retroviral Agents".
This graph shows the total number of publications written about "Anti-Retroviral Agents" by people in this website by year, and whether "Anti-Retroviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 | | 2005 | 2 | 0 | 2 | | 2006 | 1 | 0 | 1 | | 2007 | 3 | 4 | 7 | | 2008 | 5 | 0 | 5 | | 2009 | 1 | 1 | 2 | | 2010 | 6 | 2 | 8 | | 2011 | 4 | 3 | 7 | | 2012 | 5 | 2 | 7 | | 2013 | 5 | 5 | 10 | | 2014 | 19 | 5 | 24 | | 2015 | 13 | 3 | 16 | | 2016 | 8 | 1 | 9 | | 2017 | 11 | 2 | 13 | | 2018 | 16 | 3 | 19 | | 2019 | 12 | 7 | 19 | | 2020 | 3 | 3 | 6 | | 2021 | 4 | 3 | 7 | | 2022 | 0 | 4 | 4 | | 2023 | 0 | 10 | 10 | | 2024 | 1 | 5 | 6 | | 2025 | 1 | 1 | 2 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Retroviral Agents" by people in Profiles.
-
Khaitan A, Lindsey JC, Capparelli EV, Tierney C, Coletti A, Perlowski C, Yin DE, Smith MEB, Spiegel HML, Majji S, Moye J, Gama L, Koup RA, Lin BC, McDermott AB, Purdue L, Krotje C, Harding PA, Cotton MF, Costello D, Petropoulos CJ, Reeves JD, Mallewa M, Chihana R, Kamthunzi P, Mbengeranwa TG, Masheto G, Santos Cruz ML, Pilotto JH, Ponatshego PL, Persaud D, McFarland EJ. VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines. Sci Transl Med. 2026 May 06; 18(848):eadr4509.
-
Diggs MR, Chu SM, Fitch KV, Olefsky M, Watanabe MG, Erlandson KM, Lu AB, Bloomfield GS, Currier JS, Curran A, Eckard AR, Smith GHR, Sponseller CA, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Foldyna B, Taron J, Karady J, Zanni MV, Douglas PS, Ribaudo HJ, Lu MT, Grinspoon SK. Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial. AIDS. 2026 Apr 01; 40(4):428-439.
-
Edwards KA, Long D, Jones KF, Durr AL, Farel CE, Liebschutz JM, Bair MJ, Agil D, Napravnik S, Browne L, Johnson B, Thomas T, Burkholder G, Clay OJ, Demonte W, Orris SM, Johnson MO, Merlin J. The Skills to Manage Pain Randomized Trial: Results of Antiretroviral Therapy Adherence, HIV Primary Care Retention, and Virologic Suppression Outcomes. J Acquir Immune Defic Syndr. 2025 Oct 01; 100(2):180-185.
-
Stranix-Chibanda L, Brooks K, Eke AC. Care of Pregnant Women Living with Human Immunodeficiency Virus. Clin Perinatol. 2024 Dec; 51(4):749-767.
-
Masters MC, Tassiopoulos K, Bao Y, Wu K, Koletar SL, Rubin LH, Yang J, Overton ET, Letendre S, Brown TT, Erlandson KM, Palella FJ. Risk factors for progression from prediabetes to diabetes among older people with HIV. AIDS. 2024 10 01; 38(12):1740-1748.
-
Mulka KR, Queen SE, Mangus LM, Beck SE, Knight AC, McCarron ME, Solis CV, Wizzard AJ, Jayaram J, Colantuoni C, Mankowski JL. A Switch from Glial to Neuronal Gene Expression Alterations in the Spinal Cord of SIV-infected Macaques on Antiretroviral Therapy. J Neuroimmune Pharmacol. 2024 Jun 12; 19(1):28.
-
Wagner TA, Tierney C, Huang S, Nichols S, Malee KM, Montañez NA, Coletti A, Spiegel HML, Krotje C, Bone F, Wilkins M, Abuogi L, Purswani M, Bearden A, Wiznia A, Agwu A, Chadwick EG, Richman D, Gandhi M, Mehta P, Macatangay B, Spector SA, Spudich S, Persaud D, Chahroudi A. Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy. AIDS. 2024 08 01; 38(10):1494-1504.
-
Lowenthal ED, Chapman J, Ohrenschall R, Calabrese K, Baltrusaitis K, Heckman B, Yin DE, Agwu AL, Harrington C, Van Solingen-Ristea RM, McCoig CC, Adeyeye A, Kneebone J, Chounta V, Smith-Anderson C, Camacho-Gonzalez A, D'Angelo J, Bearden A, Crauwels H, Huang J, Buisson S, Milligan R, Ward S, Bolton-Moore C, Gaur AH. Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study. Lancet HIV. 2024 04; 11(4):e222-e232.
-
Burkhart Colorado AS, Lazzaro A, Neff CP, Nusbacher N, Boyd K, Fiorillo S, Martin C, Siebert JC, Campbell TB, Borok M, Palmer BE, Lozupone C. Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe. Microbiome. 2024 Feb 03; 12(1):18.
-
Pons-Faudoa FP, Di Trani N, Capuani S, Facchi I, Wood AM, Nehete B, DeLise A, Sharma S, Shelton KA, Bushman LR, Chua CYX, Ittmann MM, Kimata JT, Anderson PL, Nehete PN, Arduino RC, Grattoni A. Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques. J Control Release. 2024 02; 366:18-27.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|